- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01826578
Single Port Myomectomy Versus Conventional Myomectomy (SM)
April 3, 2013 updated by: JungRyoel Lee, Seoul National University Hospital
Prospective Randomized Controlled Trial to Analyze the Benefits of Single Port Laparoscopic Myomectomy in the View of Cosmetics and Patient Satisfaction
This study is about the evaluation of which benefits single port laparoscopic myomectomy has in the perspective of cosmetics and patient satisfaction.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
There were several studies about feasibility and cosmetic benefit of single port laparoscopic adnexal surgery and hysterectomy compared to conventional multiport laparoscopic surgery.
Meanwhile, no study mentioned benefit of single port laparoscopic surgery in myomectomy because single port myomectomy needs more labor and operator's skill than other pelvic surgery.
At this point, the investigators need to verify the effectiveness and benefit of single port laparoscopic myomectomy.
Study Type
Interventional
Enrollment (Anticipated)
106
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kyeonggi-do
-
Sungnam-si, Kyeonggi-do, Korea, Republic of, 463-707
- Seoul University Bundang Hospital OB & GY
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- premenopausal women
- image confirmed myoma
- scheduled to have laparoscopic myomectomy
- number of myoma =<4 and largest size <10cm
Exclusion Criteria:
- scheduled to have co-operation of other surgery
- clinically significant hematologic abnormality
- DM or malnutrition
- under the medication which can affect wound healing
- previous history of other pelvic surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: single port arm
|
using only one port for laparoscopic surgery
Other Names:
|
|
No Intervention: Conventional arm
Using 3-4 port for laparosocpic surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cosmetic benefits of single port laparoscopic myomectomy to conventional myomectomy in the view of scar evaluation
Time Frame: for 8 weeks
|
The characteristics of scar such as color, pliability, and stiffness are willing to be measured in 1 week and 8 week later after myomectomy.
The level of satisfaction of patients will also be evaluated.
|
for 8 weeks
|
|
Cosmetic benefits of single port laparoscopic myomectomy to conventional myomectomy in the view of patient satisfaction
Time Frame: for 8 weeks
|
Patient satisfaction about scar formation after myomectomy are willing to be evaluated after surgery.
|
for 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
General composite characteristics of surgery procedure and outcome
Time Frame: 1 week
|
Composite parameters about surgery outcome and complication such as Op time, Drop of Hb, postop pain, duration of hospital stay, intraop complication, postop complication are willing to be measured.
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2013
Primary Completion (Anticipated)
September 1, 2014
Study Completion (Anticipated)
December 1, 2014
Study Registration Dates
First Submitted
March 22, 2013
First Submitted That Met QC Criteria
April 3, 2013
First Posted (Estimate)
April 8, 2013
Study Record Updates
Last Update Posted (Estimate)
April 8, 2013
Last Update Submitted That Met QC Criteria
April 3, 2013
Last Verified
April 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- jrlee01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.